Rep. DeGette Raises Concerns Over Administration's Plan to Greenlight Unproven COVID-19 Tests for Market
October 08, 2020
October 08, 2020
WASHINGTON, Oct. 8 -- Rep. Diana DeGette, D-Colorado, issued the following news release on Oct. 7:
U.S. Rep. Diana DeGette (D-CO), chair of the House Energy and Commerce Committee's Oversight and Investigations panel - which directly oversees the Dept. of Health and Human Services and the Food and Drug Administration - sent a letter today to HHS Secretary Alex Azar raising serious concerns over the agency's decision to allow laboratory-developed tests, or LDTs, for COVID-1 . . .
U.S. Rep. Diana DeGette (D-CO), chair of the House Energy and Commerce Committee's Oversight and Investigations panel - which directly oversees the Dept. of Health and Human Services and the Food and Drug Administration - sent a letter today to HHS Secretary Alex Azar raising serious concerns over the agency's decision to allow laboratory-developed tests, or LDTs, for COVID-1 . . .